The Department of Health and Social Care (DHSC) has today (28/04/2023) granted the following final list of price concessions for April 2023: Drug Pack size Price concession Amoxicillin 125mg/5ml oral suspension 100 £3.46 Amoxicillin 125mg/5ml oral suspension sugar free 100 £3.29 Baclofen 5mg/5ml oral solution sugar free 300 £5.99 Benzoyl peroxide 5% / Clindamycin 1% [...]
The post April 2023 Price Concessions Final Update appeared first on PSNC Website.
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 9 April 2023) has been published and includes articles on: Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months. Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular eventss, malignancy, venous thromboembolism, serious infections [...]
The post MHRA Drug Safety Update April 2023 appeared first on PSNC Website.
Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd) Drug alert number: EL (23)A/15 Date issued: 26 April 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name:Beconase Hayfever Nasal Spray, PL 02855/0064 (Omega Pharma Ltd) SNOMED Code:2945411000001101 Batch No Expiry [...]
The post Class 4 Medicines Defect Information: Beconase Hayfever Nasal Spray (Omega Pharma Ltd) appeared first on PSNC Website.
The Department of Health and Social Care (DHSC) has today (25/04/2023) granted the following list of price concessions for April 2023: Drug Pack size Price concession Buprenorphine 8mg sublingual tablets sugar free 7 £4.41 Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment 30 £9.23 Carbocisteine 375mg capsules 120 £7.24 Chloramphenicol 1% eye ointment 4 £5.20 Chlorpromazine [...]
The post April 2023 Price Concessions 3rd Update appeared first on PSNC Website.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin 5mg modified-release tablets. MSN/2023/048 Tier 2 – medium impact Date of issue 24th April 2023 Oxybutynin 5mg modified-release tablets are out of stock until w/c 1st May 2023. Oxybutynin immediate release formulations (tablets and liquid) remain available and can support [...]
The post Medicine Supply Notification: Oxybutynin 5mg modified-release tablets appeared first on PSNC Website.
Recent Comments